Novel hydrate form of O-desmethyl venlafaxine succinate

Details for Australian Patent Application No. 2007283215 (hide)

Owner Generics [UK] Limited Merck Development Center Private Limited

Inventors Wavhal, S.R.; Wakchaure, V.S.; Gore, Vinayak G; Kulkarni, Vikas S.; Hublikar, M.G.

Agent Spruson & Ferguson

Pub. Number AU-A-2007283215

PCT Pub. Number WO2008/017886

Priority 1256/mum/2006 08.08.06 IN

Filing date 8 August 2007

Wipo publication date 14 February 2008

International Classifications

C07C 215/64 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/017886 Priority application(s): WO2008/017886

8 October 2009 Assignment before Grant

  Generics [UK] Limited; Merck Development Center Private Limited The application has been assigned to Generics [UK] Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007283221-Improvements relating to humidification chambers

2007283212-4-oxo-4,5-dihydropyrrolo[1,2-A] quinoxaline derivatives as inhibitors of poly(ADP-ribose)polymerase(PARP)